332 related articles for article (PubMed ID: 12940539)
1. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations.
Silverberg DS; Wexler D; Blum M; Iaina A
Clin Nephrol; 2003 Jul; 60 Suppl 1():S93-102. PubMed ID: 12940539
[TBL] [Abstract][Full Text] [Related]
2. The interaction between heart failure and other heart diseases, renal failure, and anemia.
Silverberg DS; Wexler D; Iaina A; Schwartz D
Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
[TBL] [Abstract][Full Text] [Related]
4. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
Silverberg DS; Wexler D; Iaina A
J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047
[TBL] [Abstract][Full Text] [Related]
5. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
Iaina A; Silverberg DS; Wexler D
Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin in heart failure.
Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
[TBL] [Abstract][Full Text] [Related]
7. Anaemia as a contributor to morbidity and mortality in congestive heart failure.
Wexler D; Silverberg D; Blum M; Sheps D; Keren G; Wollman Y; Schwartz D; Iaina A
Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii11-5. PubMed ID: 16024826
[TBL] [Abstract][Full Text] [Related]
8. The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.
Silverberg DS; Wexler D; Blum M; Tchebiner J; Sheps D; Keren G; Schwartz D; Baruch R; Yachnin T; Shaked M; Zubkov A; Steinbruch S; Iaina A
Clin Nephrol; 2002 Jul; 58 Suppl 1():S37-45. PubMed ID: 12227725
[TBL] [Abstract][Full Text] [Related]
9. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
[TBL] [Abstract][Full Text] [Related]
10. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.
Usmanov RI; Zueva EB; Silverberg DS; Shaked M
J Nephrol; 2008; 21(2):236-42. PubMed ID: 18446719
[TBL] [Abstract][Full Text] [Related]
11. Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians.
Silverberg DS; Wexler D; Blum M; Schwartz D; Keren G; Sheps D; Iaina A
Isr Med Assoc J; 2003 May; 5(5):337-9. PubMed ID: 12811950
[TBL] [Abstract][Full Text] [Related]
12. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.
Palazzuoli A; Silverberg DS; Iovine F; Calabrò A; Campagna MS; Gallotta M; Nuti R
Am Heart J; 2007 Oct; 154(4):645.e9-15. PubMed ID: 17892986
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure.
Wexler D; Silverberg D; Sheps D; Blum M; Keren G; Iaina A; Schwartz D
Int J Cardiol; 2004 Jul; 96(1):79-87. PubMed ID: 15203265
[TBL] [Abstract][Full Text] [Related]
14. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists.
Silverberg DS; Wexler D; Iaina A; Steinbruch S; Wollman Y; Schwartz D
Int Urol Nephrol; 2006; 38(2):295-310. PubMed ID: 16868702
[TBL] [Abstract][Full Text] [Related]
15. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
16. The cardio-renal anemia syndrome.
Iaina A; Silverberg DS; Wexler D; Iaina Nomy L
Med Pregl; 2007; 60 Suppl 2():145-50. PubMed ID: 18928182
[TBL] [Abstract][Full Text] [Related]
17. The interaction between heart failure, renal failure and anemia - the cardio-renal anemia syndrome.
Silverberg DS; Wexler D; Blum M; Wollman Y; Schwartz D; Sheps D; Keren G; Iaina A
Blood Purif; 2004; 22(3):277-84. PubMed ID: 15166489
[TBL] [Abstract][Full Text] [Related]
18. Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure.
Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Scherhag A; Schwartz D
Kidney Blood Press Res; 2005; 28(1):41-7. PubMed ID: 15489560
[TBL] [Abstract][Full Text] [Related]
19. Anemia and chronic heart failure implications and treatment options.
Anand IS
J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
[TBL] [Abstract][Full Text] [Related]
20. Are hematinic deficiencies the cause of anemia in chronic heart failure?
Witte KK; Desilva R; Chattopadhyay S; Ghosh J; Cleland JG; Clark AL
Am Heart J; 2004 May; 147(5):924-30. PubMed ID: 15131553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
